Related Experiment Video

Updated: Mar 19, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K

MKP1 mediates resistance to therapy in HER2-positive breast tumors

Demet Candas1, Jian Jian Li1

  • 1School of Medicine; Department of Radiation Oncology; NCI-designated Comprehensive Cancer Center; University of California Davis ; Sacramento, CA, USA.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Mitogen-activated protein kinase phosphatase 1 (MKP1) is overexpressed in breast cancer and linked to therapy resistance. Targeting MKP1 in HER2-positive tumors may improve cancer treatment efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Mitogen-activated protein kinase phosphatase 1 (MKP1), also known as DUSP1, is an antiapoptotic enzyme.
  • MKP1 is frequently overexpressed in various cancers, including breast cancer.
  • Elevated MKP1 expression is observed in radiation-treated breast cancer cells and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression.

Purpose of the Study:

  • To investigate the role of MKP1 in breast cancer, particularly in relation to HER2 expression and therapy resistance.
  • To explore the potential of targeting MKP1 as a therapeutic strategy for HER2-positive breast tumors.

Main Methods:

  • Analysis of MKP1 expression in breast cancer cells.
  • Correlation studies between MKP1, radiation treatment, and HER2 expression.
  • Evaluation of MKP1's role in therapeutic resistance.

Main Results:

  • MKP1 is overexpressed in breast cancer and its expression can be induced by radiation.
  • MKP1 expression positively correlates with HER2 expression in breast cancer.
  • MKP1 plays a role in resistance to cancer therapies.

Conclusions:

  • MKP1 is an antiapoptotic phosphatase implicated in breast cancer progression and therapy resistance.
  • Targeting MKP1 in HER2-positive breast cancer presents a promising strategy to enhance the effectiveness of existing therapies, including anti-HER2 treatments.
Keywords:
HER2MKP1breast cancermitochondriaradioresistance

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

9.3K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
7
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K